Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Current amyloid-beta drugs of interest for AD.
| Therapy Type | Drug Name | FDA Status |
|---|---|---|
| Passive immunotherapy | Solanezumab | Phase 3 |
| Passive immunotherapy | Gantenerumab | Phase 3 |
| Passive immunotherapy | Lecanemab | Phase 3 |
| Passive immunotherapy | Crenezumab | Phase 3 |
| Passive immunotherapy | Donanemab | Phase 3 |
| Active immunotherapy | UB-311 | Phase 3 |
| Active immunotherapy | ABvac 40 | Phase 2 |
| Combination, Small Molecule | ALZT-OP1 | Phase 3 |
| Small Molecule | GV-971 | Alzheimer’s Disease (Inactive) Approved in China |
